NATCO PHARMA LTD. (NATCOPHARM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.[1]NATCO has established its presence in all three business segments viz. finished dosage…

NATCOPHARMUpdated 29 Aug 2026, 2:51

Natco Pharma Ltd.

Market Cap

₹15,292Cr.

Current Price

₹854

High / Low

₹1,227/789

Stock P/E

17.1

ROE16.1%
ROCE16.6%
Book Value₹478
Face Value₹2.00
Dividend Yield0.59%

About

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.[1]NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days968887106901098811912311010577
Inventory Days424501215400547482562476424379395460
Days Payable24738516023121721510296126116138232
Cash Conversion Cycle274205142275420376548499422373362305
Working Capital Days208673222215310297268213153149159
ROCE %18%18%39%34%24%14%9%3%16%29%32%17%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:51


Designed & Shipped by Harshit Bansal